Literature DB >> 16462412

Metabolic syndrome in the acute care setting.

Patricia M Selig1.   

Abstract

The metabolic syndrome is a clinical condition that is a powerful predictor for cardiovascular morbidity and mortality. Hypertension, abdominal obesity, high blood glucose levels, and abnormal blood lipid levels characterize metabolic syndrome. Therapeutic treatment of the metabolic syndrome confers a significant risk reduction for both type 2 diabetes and premature cardiovascular events. In the hospital setting, the management of hyperglycemia, one of the clinical components of the metabolic syndrome, has been secondary in importance to the condition that prompted admission. Hyperglycemia in the hospitalized patient has been associated with increased lengths of stay, higher rates of hospital-acquired infections, and increased mortality. Early recognition and treatment of hyperglycemia and the associated metabolic components that comprise the metabolic syndrome may reduce morbidity and mortality in the hospital setting. More aggressive interventions will aid in reducing costs while simultaneously improving patient care and safety.

Entities:  

Mesh:

Year:  2006        PMID: 16462412     DOI: 10.1097/00044067-200601000-00010

Source DB:  PubMed          Journal:  AACN Clin Issues        ISSN: 1079-0713


  1 in total

Review 1.  The Role of Hepatocyte Growth Factor (HGF) in Insulin Resistance and Diabetes.

Authors:  Alexandre G Oliveira; Tiago G Araújo; Bruno de Melo Carvalho; Guilherme Z Rocha; Andrey Santos; Mario J A Saad
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-30       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.